<DOC>
	<DOCNO>NCT02784717</DOCNO>
	<brief_summary>This non-interventional field study investigate rivaroxaban clinical practice condition stroke prevention prevention non-CNS systemic embolism patient non-valvular atrial fibrillation China .</brief_summary>
	<brief_title>Xarelto Prevention Stroke Non-central Nervous System Systemic Embolism Patients With Non-valvular Atrial Fibrillation China : A Non-interventional Study</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Female male patient â‰¥ 18 year age diagnose nonvalvular atrial fibrillation Patients decision initiate treatment rivaroxaban prevent stroke nonCNS systemic embolism make per investigator 's routine treatment practice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>rivaroxaban ,</keyword>
	<keyword>non-interventional ,</keyword>
	<keyword>atrial fibrillation ,</keyword>
	<keyword>stroke prevention ,</keyword>
</DOC>